Intrathecal antibodies and brain damage in autoimmune MRL mice

Brain, Behavior, and Immunity

Volumn 24, Issue 2, 2010, Pages 289-297

  Stanojcic, Mile ^a   Loheswaran, Genane ^a   Xu, Li ^a   Hoffman, Steven A ^b   Sakic, Boris ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Autoimmunity; Brain damage; Brain reactive antibodies; Cerebrospinal fluid; Lupus; MRL model; Neurodegeneration

Indexed keywords

BRAIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BEHAVIOR DISORDER; BRAIN DAMAGE; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DENTATE GYRUS; FORCED SWIMMING TEST; IMMUNOREACTIVITY; MALE; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SUBVENTRICULAR ZONE; SYSTEMIC LUPUS ERYTHEMATOSUS; THALAMUS MIDLINE NUCLEUS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM; DEPRESSION; EMOTIONS; EXPLORATORY BEHAVIOR; FOOD PREFERENCES; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED MRL LPR; MOTOR ACTIVITY; PERIPHERAL NERVOUS SYSTEM; POSTURAL BALANCE; SWIMMING; TASTE; TISSUE FIXATION;

EID: 72649093914     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.10.009     Document Type: Article

References (81)

1. Abbott N.J., Mendonca L.L., and Dolman D.E. The blood-brain barrier in systemic lupus erythematosus. Lupus 12 (2003) 908-915
2. ACR ad hoc committee, 1999. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 42, 599-608.
3. Alexander J.J., and Quigg R.J. Systemic lupus erythematosus and the brain: what mice are telling us. Neurochem. Int. 50 (2007) 5-11
4. Alexander E.L., Murphy E.D., Roths J.B., and Alexander G.E. Congenic autoimmune murine models of central nervous system disease in connective tissue disorders. Ann. Neurol. 14 (1983) 242-248
5. Anderson K.K., Ballok D.A., Prasad N., Szechtman H., and Sakic B. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice. Behav. Brain Res. 166 (2006) 32-38
6. Arinuma Y., Yanagida T., and Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 58 (2008) 1130-1135
7. Ballok D.A. Neuroimmunopathology in a murine model of neuropsychiatric lupus. Brain Res. Rev. 54 (2007) 67-79
8. Ballok D.A., Millward J.M., and Sakic B. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Brain Res. 964 (2003) 200-210
9. Ballok D.A., Szechtman H., and Sakic B. Taste responsiveness and diet preference in autoimmune MRL mice. Behav. Brain Res. 140 (2003) 119-130
10. Ballok D.A., Earls A.M., Krasnik C., Hoffman S.A., and Sakic B. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice. J. Neuroimmunol. 152 (2004) 83-97
11. Bergquist J., Traskman-Bendz L., Lindstrom M.B., and Ekman R. Suicide-attempters having immunoglobulin G with affinity for dopamine in cerebrospinal fluid. Eur. Neuropsychopharmacol. 12 (2002) 153-158
12. Bluestein H.G., Williams G.W., and Steinberg A.D. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am. J. Med. 70 (1981) 240-246
13. Brenner R.M., Slayden O.D., Rodgers W.H., Critchley H.O., Carroll R., Nie X.J., and Mah K. Immunocytochemical assessment of mitotic activity with an antibody to phosphorylated histone H3 in the macaque and human endometrium. Hum. Reprod. 18 (2003) 1185-1193
14. Bresnihan B., Hohmeister R., Cutting J., Travers R.L., Waldburger M., Black C., Jones T., and Hughes G.R. The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms. Ann. Rheum. Dis. 38 (1979) 301-306
15. Chun S., McEvilly R., Foster J.A., and Sakic B. Proclivity to self-injurious behavior in MRL-lpr mice. implications for autoimmunity-induced damage in the dopaminergic system. Mol. Psychiatry 13 (2008) 1043-1053
16. Costall B., Eniojukan J.F., and Naylor R.J. Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse. Psychopharmacology (Berl.) 86 (1985) 452-457
17. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., and Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7 (2001) 1189-1193
18. Denburg J.A., Carbotte R.M., and Denburg S.D. Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 37 (1987) 464-467
19. Denenberg V.H., Sherman G.F., Rosen G.D., Morrison L., Behan P.O., and Galaburda A.M. A behavior profile of the MRL/Mp lpr/lpr mouse and its association with hydrocephalus. Brain Behav. Immun. 6 (1992) 40-49
20. Depoortere R., Bardin L., Auclair A.L., Kleven M.S., Prinssen E., Colpaert F., Vacher B., and Newman-Tancredi A. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia. Br. J. Pharmacol. 151 (2007) 253-265
21. Farrell M., Sakic B., Szechtman H., and Denburg J.A. Effect of cyclophosphamide on leucocytic infiltration in the brain of MRL/lpr mice. Lupus 6 (1997) 268-274
22. Fragoso-Loyo H., Cabiedes J., Orozco-Narvaez A., Davila-Maldonado L., Atisha-Fregoso Y., Diamond B., Llorente L., and Sanchez-Guerrero J. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One 3 (2008) e3347
23. Gao H.X., Campbell S.R., Cui M.H., Zong P., Hee-Hwang J., Gulinello M., and Putterman C. Depression is an early disease manifestation in lupus-prone MRL/lpr mice. J. Neuroimmunol. 207 (2009) 45-56
24. Greenwood D.L., Gitlits V.M., Alderuccio F., Sentry J.W., and Toh B.H. Autoantibodies in neuropsychiatric lupus. Autoimmunity 35 (2002) 79-86
25. Hanly J.G., Robichaud J., and Fisk J.D. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J. Rheumatol. 33 (2006) 1553-1558
26. Harris E.N., and Pierangeli S. Antiphospholipid antibodies and cerebral lupus. Ann. NY Acad. Sci. 823 (1997) 270-278
27. Harrison M.J., Ravdin L.D., and Lockshin M.D. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum. 54 (2006) 2515-2522
28. Henneberg A., Mayle D.M., and Kornhuber H.H. Antibodies to brain tissue in sera of patients with chronic progressive multiple sclerosis. J. Neuroimmunol. 34 (1991) 223-227
29. Hirohata S., Arinuma Y., Takayama M., and Yoshio T. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res. Ther. 9 (2007) R44
30. Hoffman S.A., Hoffman A.A., Shucard D.W., and Harbeck R.J. Antibodies to dissociated cerebellar cells in New Zealand mice as demonstrated by immunofluorescence. Brain Res. 142 (1978) 477-486
31. Hu Y., Dietrich H., Herold M., Heinrich P.C., and Wick G. Disturbed immuno-endocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease. Int. Arch. Allergy Immunol. 102 (1993) 232-241
32. Huerta P.T., Kowal C., DeGiorgio L.A., Volpe B.T., and Diamond B. Immunity and behavior: antibodies alter emotion. Proc. Natl. Acad. Sci. USA 103 (2006) 678-683
33. Katsumata Y., Harigai M., Kawaguchi Y., Fukasawa C., Soejima M., Takagi K., Tanaka M., Ichida H., Tochimoto A., Kanno T., Nishimura K., Kamatani N., and Hara M. Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin. J. Rheumatol. 34 (2007) 2010-2017
34. Katzav A., Solodeev I., Brodsky O., Chapman J., Pick C.G., Blank M., Zhang W., Reichlin M., and Shoenfeld Y. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum. 56 (2007) 938-948
35. Katzav A., Ben-Ziv T., Chapman J., Blank M., Reichlin M., and Shoenfeld Y. Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS-SLE (depression). J. Autoimmun. 31 (2008) 393-398
36. Kowal C., DeGiorgio L.A., Nakaoka T., Hetherington H., Huerta P.T., Diamond B., and Volpe B.T. Cognition and immunity; antibody impairs memory. Immunity 21 (2004) 179-188
37. Kowal C., DeGiorgio L.A., Lee J.Y., Edgar M.A., Huerta P.T., Volpe B.T., and Diamond B. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. USA 103 (2006) 19854-19859
38. Lai N.S., and Lan J.L. Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations. Lupus 9 (2000) 353-357
39. Lapteva L., Nowak M., Yarboro C.H., Takada K., Roebuck-Spencer T., Weickert T., Bleiberg J., Rosenstein D., Pao M., Patronas N., Steele S., Manzano M., van d. V., Lipsky P.E., Marenco S., Wesley R., Volpe B., Diamond B., and Illei G.G. Anti-N-methyl-d-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum. 54 (2006) 2505-2514
40. Lechner O., Hu Y., Jafarian-Tehrani M., Dietrich H., Schwarz S., Herold M., Haour F., and Wick G. Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in murine lupus. Brain Behav. Immun. 10 (1996) 337-350
41. Lechner O., Dietrich H., Oliveira dos S.A., Wiegers G.J., Schwarz S., Harbutz M., Herold M., and Wick G. Altered circadian rhythms of the stress hormone and melatonin response in lupus-prone MRL/MP-fas(Ipr) mice. J. Autoimmun. 14 (2000) 325-333
42. Lee J.Y., Huerta P.T., Zhang J., Kowal C., Bertini E., Volpe B.T., and Diamond B. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat. Med. 15 (2009) 91-96
43. Ma X., Foster J., and Sakic B. Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice. J. Neuroimmunol. 179 (2006) 26-36
44. Margutti P., Delunardo F., and Ortona E. Autoantibodies associated with psychiatric disorders. Curr. Neurovasc. Res. 3 (2006) 149-157
45. Maric D., Millward J.M., Ballok D.A., Szechtman H., Barker J.L., Denburg J.A., and Sakic B. Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice. Brain Res. 920 (2001) 183-193
46. McLean B.N., Miller D., and Thompson E.J. Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet's disease involving the nervous system. J. Neurol. Neurosurg. Psychiatry 58 (1995) 548-554
47. Monleon S., D'Aquila P., Parra A., Simon V.M., Brain P.F., and Willner P. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology (Berl.) 117 (1995) 453-457
48. Park C., Sakamaki K., Tachibana O., Yamashima T., Yamashita J., and Yonehara S. Expression of Fas antigen in the normal mouse brain. Biochem. Biophys. Res. Commun. 252 (1998) 623-628
49. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229 (1977) 327-336
50. Sakic B., Szechtman H., Keffer M., Talangbayan H., Stead R., and Denburg J.A. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav. Immun. 6 (1992) 265-285
51. Sakic B., Szechtman H., Denburg S.D., Carbotte R.M., and Denburg J.A. Brain-reactive antibodies and behavior of autoimmune MRL-lpr mice. Physiol. Behav. 54 (1993) 1025-1029
52. Sakic B., Szechtman H., Denburg S.D., Carbotte R.M., and Denburg J.A. Spatial learning during the course of autoimmune disease in MRL mice. Behav. Brain Res. 54 (1993) 57-66
53. Sakic B., Szechtman H., Talangbayan H., Denburg S.D., Carbotte R.M., and Denburg J.A. Behaviour and immune status of MRL mice in the postweaning period. Brain Behav. Immun. 8 (1994) 1-13
54. Sakic B., Szechtman H., Talangbayan H., Denburg S.D., Carbotte R.M., and Denburg J.A. Disturbed emotionality in autoimmune MRL-lpr mice. Physiol. Behav. 56 (1994) 609-617
55. Sakic B., Szechtman H., Denburg S.D., and Denburg J.A. Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice. Physiol. Behav. 58 (1995) 797-802
56. Sakic B., Denburg J.A., Denburg S.D., and Szechtman H. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Res. Bull. 41 (1996) 305-311
57. Sakic B., Szechtman H., Stead R., and Denburg J.A. Joint pathology and behavioral performance in autoimmune MRL-lpr mice. Physiol. Behav. 60 (1996) 901-905
58. Sakic B., Szechtman H., and Denburg J.A. Neurobehavioral alteration in autoimmune mice. Neurosci. Biobehav. Rev. 21 (1997) 327-340
59. Sakic B., Szechtman H., Denburg J.A., Gorny G., Kolb B., and Whishaw I.Q. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. J. Neuroimmunol. 87 (1998) 162-170
60. Sakic B., Laflamme N., Crnic L.S., Szechtman H., Denburg J.A., and Rivest S. Reduced corticotropin-releasing factor and enhanced vasopressin gene expression in brains of mice with autoimmunity-induced behavioral dysfunction. J. Neuroimmunol. 96 (1999) 80-91
61. Sakic B., Lacosta S., Denburg J., and Szechtman H. Altered neurotransmission in brains of autoimmune mice: pharmacological and neurochemical evidence. J. Neuroimmunol. 129 (2002) 84-96
62. Sakic B., Hanna S.E., and Millward J.M. Behavioral heterogeneity in an animal model of neuropsychiatric lupus. Biol. Psychiatry 57 (2005) 679-687
63. Sakic B., Kirkham D.L., Ballok D.A., Mwanjewe J., Fearon I.M., Macri J., Yu G., Sidor M.M., Denburg J.A., Szechtman H., Lau J., Ball A.K., and Doering L.C. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. J. Neuroimmunol. 169 (2005) 68-85
64. Schott K., Schaefer J.E., Richartz E., Batra A., Eusterschulte B., Klein R., Berg P.A., Bartels M., Mann K., and Buchkremer G. Autoantibodies to serotonin in serum of patients with psychiatric disorders. Psychiatry Res. 121 (2003) 51-57
65. Shanks N., Moore P.M., Perks P., and Lightman S.L. Alterations in hypothalamic-pituitary-adrenal function correlated with the onset of murine SLE in MRL +/+ and lpr/lpr mice. Brain Behav. Immun. 13 (1999) 348-360
66. Sidor M.M., Sakic B., Malinowski P.M., Ballok D.A., Oleschuk C.J., and Macri J. Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice. J. Neuroimmunol. 165 (2005) 104-113
67. Sled J.G., Spring S., van E.M., Lerch J.P., Ullal S., and Sakic B. Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus. Arthritis Rheum. 60 (2009) 1764-1774
68. Stanojcic M., Burstyn-Cohen T., Nashi N., Lemke G., and Sakic B. Disturbed distribution of proliferative brain cells during lupus-like disease. Brain Behav. Immun. 23 (2009) 1003-1013
69. Surget A., and Belzung C. Involvement of vasopressin in affective disorders. Eur. J. Pharmacol. 583 (2008) 340-349
70. Szechtman, H., Denburg, J.A., Sakic, B., 1995. Neurobehavioural dysfunction in lupus-prone MRL mice. Lupus 4 (Supp. 2), 52 (abstract).
71. Theofilopoulos A.N. Murine models of lupus. In: Lahita R.G. (Ed). Systemic Lupus Erythematosus (1992), Churchill Livingstone, New York 121-194
72. Toubi E., and Shoenfeld Y. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun. Rev. 6 (2007) 119-125
73. Vogelweid C.M., Johnson G.C., Besch-Williford C.L., Basler J., and Walker S.E. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. J. Neuroimmunol. 35 (1991) 89-99
74. Wick G., Hu Y., Schwarz S., and Kroemer G. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocr. Rev. 14 (1993) 539-563
75. Williams G.W., Bluestein H.G., and Steinberg A.D. Brain-reactive lymphocytotoxic antibody in the cerebrospinal fluid of patients with systemic lupus erythematosus: correlation with central nervous system involvement. Clin. Immunol. Immunopathol. 18 (1981) 126-132
76. Yoshio T., Hirata D., Onda K., Nara H., and Minota S. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus. J. Rheumatol. 32 (2005) 34-39
77. Yoshio T., Onda K., Nara H., and Minota S. Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 54 (2006) 675-678
78. Zameer A., and Hoffman S.A. Immunoglobulin binding to brain in autoimmune mice. J. Neuroimmunol. 120 (2001) 10-18
79. Zameer A., and Hoffman S.A. Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice. J Neuroimmunol. 142 (2003) 67-74
80. Zameer A., and Hoffman S.A. B and T cells in the brains of autoimmune mice. J. Neuroimmunol. 146 (2004) 133-139
81. Zandman-Goddard G., Chapman J., and Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin. Arthritis Rheum. 36 (2007) 297-315